ResearcherNankai UniversityActive in the last 2 years
Yuanke Li
Matched on ORCID iD 0000-0002-8304-8768; OpenAlex author ID A5101781400. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 2 papers
Papers 4
- Small extracellular vesicles (sEVs) in pancreatic cancer progression and diagnosis. Co-author DOI 10.1016/j.jconrel.2025.01.072↗
- Oncolytic virus-induced IL-1β+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer. Co-author DOI 10.1136/jitc-2025-013175↗
- Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer. Co-author DOI 10.7150/thno.53102↗
- Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma. Co-author DOI 10.1021/acsami.9b15116↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kun Cheng · 3 shared papers, 2019–2025 · strength 0.56
- Paper Small extracellular vesicles (sEVs) in pancreatic cancer progression and diagnosis. DOI 10.1016/j.jconrel.2025.01.072↗
- Paper Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer. DOI 10.7150/thno.53102↗
- Paper Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma. DOI 10.1021/acsami.9b15116↗
- Reaid Hasan · 1 shared paper, 2025 · strength 0.30
- Fan Li · 1 shared paper, 2025 · strength 0.19
- Jie Wang · 1 shared paper, 2025 · strength 0.19
- Shiyu Liu · 1 shared paper, 2025 · strength 0.19
- Youjia Cao · 1 shared paper, 2025 · strength 0.19
- Hongkai Zhang · 1 shared paper, 2025 · strength 0.19
- Feilong Zhou · 1 shared paper, 2025 · strength 0.19
- Zhaoyuan Zhang · 1 shared paper, 2025 · strength 0.19
- Guangfu Li · 1 shared paper, 2021 · strength 0.15
- Hao Liu · 1 shared paper, 2019 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.